CARGO Therapeutics stockholders elect three Class II directors and ratify auditor at 2025 annual meeting

CARGO Therapeutics, Inc.

Stockholders elected Abraham Bassan, Kapil Dhingra, and David Lubner as Class II directors to serve until 2028.
Ratified Deloitte & Touche as independent auditor for fiscal year ending Dec 31, 2025 with 39,832,056 votes for.
Meeting held June 18, 2025; 46,110,228 shares outstanding as of record date April 21, 2025.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.